Abstract. The presence of cancer stem cells (CSCs) has major implications in the choice of cancer treatment strategy and is responsible for tumor relapse. CSCs have been isolated and characterized in several types of cancer; however, studies concerning the CSCs from nasopharyngeal carcinoma (NPC) are limited. Thus, the present study was designed to isolate and characterize the cancer stem-like side population (SP) cells from NPC samples. The fluorescence-activated cell sorting (FACS)-based Hoechst 33342 dye exclusion technique identified that 3.9% of cells from NPC samples were cancer stem-like SP cells. Upon treatment with verapamil (ABC transporter inhibitor), the percentage of SP cells was significantly reduced to 0.7%, which confirms that the ABC transporter protein exhibits a significant role in drug exclusion. Fluorescence microscopy analysis revealed that the FACS purified SP cells showed increased expression of ABCG2 (ATP transporter protein), Oct-4 and CD44 (stem cell surface protein). Furthermore, these SP cells exhibited increased mRNA expression of ABCG2 and anti-apoptotic factor Bmi-1, which contribute to multi-drug resistance and increased cell survival rate. Notably, the Wnt/β-catenin signaling pathways are altered in SP cells. In addition, using reverse transcription-quantitative polymerase chain reaction analysis it was observed that the cells exhibited increased expression of DKK1 and AXIN2. In conclusion, data from the present study clearly demonstrated that the presence of cancer stem-like SP cells from NPC may be responsible for chemotherapeutic drug resistance, tumor recurrence and invasion.
Introduction
Nasopharyngeal carcinoma (NPC) is the most common type of cancer that originates in the upper region of the pharynx, and commonly occurs in males and females worldwide (1) . Despite recent advances in the treatment strategy, treatment failure and tumor relapse render complete eradication of tumors difficult due to the presence of cancer stem cells (CSCs). The recently proposed CSC theory states that the presence of a small sub-population of cancer cells within the tumor, termed CSCs can cause resistance to therapy and tumor recurrence. Current conventional treatment strategies kill the majority of the neoplastic cells; however, the CSCs are not targeted efficiently and thus are responsible for minimal residual disease (MRD). Therefore it is necessary to target and kill CSCs in order to achieve the complete eradication of tumor cells and to provide long-term disease free survival.
Cancer stem cells have been isolated and characterized in several types of solid tumor by two different methods. Firstly using the expression of stem cell surface markers, such as CD133 and CD44 (2) and secondly using the Hoechst 33342 dye exclusion technique (3) . A small population of cells exhibited a distinct FACS profile to the side of the predominant population due to a more efficient Hoechst 33342 dye efflux and lower fluorescent intensity signal. These cells are designated as side population (SP) cells and have been recently well-characterized in several types of tumor, such as small cell lung cancer, glioma, prostate cancer, leukemia, neuroblastoma, hepatoma, nasopharyngeal carcinoma, colorectal cancer, thyroid cancer and lung cancer (3) (4) (5) (6) (7) (8) (9) (10) (11) . These SP cells exhibit characteristic features of CSCs, such as chemotherapy and apoptosis resistance, elevated expression of ABC transporter proteins, self-renewal capacity, expression of stem cell surface markers, high tumorigenicity and differentiation potential (12) (13) (14) . Moreover, SP cells were highly invasive and exhibited abnormal activation of Wnt/β-catenin signaling pathways (15) . Therefore, these SP cells are considered as enriched CSCs. Hence, isolation and characterization of these SP cells may aid in elucidating the molecular mechanism underlying the tumorigenesis mediated by CSCs in NPC and Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma GUO 
Materials and methods
Sample collection and cell culture. NPC samples were collected at the time of surgery according to the ethical approval. Stage IV, infratemporal NPC samples were taken from 15 patients. The cancer tissues were washed extensively in phosphate-buffered saline (PBS) solution containing antibiotics (Sigma-Aldrich, St. Louis, MO, USA) and were incubated overnight in Dulbecco's modified Eagle's medium (DMEM/F12; Gibco-BRL, Carlsbad, CA, USA) containing 500 U/ml penicillin, 500 µg/ml streptomycin and 1.25 µg/ml amphotericin B (Gibco-BRL). Enzymatic digestion was performed using 1.5 mg/ml collagenase (Gibco-BRL) and 20 µg/ml hyaluronidase (Sigma-Aldrich) in PBS for 1 h. Cells were cultured in DMEM with 10% fetal bovine serum (FBS; Sigma-Aldrich), supplemented with antibiotics and maintained in T-75 flasks at 37˚C in a humidified 5% CO 2 and 95% air atmosphere. When cells were 90% confluent, they were removed from the culture flask using Trypsin-EDTA (0.25%-53 mM EDTA) washed with phosphate-buffered saline (PBS), and suspended in 10% DMEM. Cells were counted using a hemocytometer (Z359629; Bright-Line, Sigma-Aldrich, St. Louis, MO, USA). The present study was approved by the Ethics Committee of Tumor Hospital of Jilin Province, (Jilin, China).
Labeling with Hoechst 33342 dye. Groups consisted of: Control, cells labeled with Hoechst 33342 dye alone (n=9); and drug treated, cells treated with verapamil (Sigma-Aldrich) and labeled with Hoechst 33342 dye (n=9; Sigma-Aldrich). Cells were counted by a hemocytometer and ~10 6 cells/ml in 10% DMEM were labeled with Hoechst 33342 stock (sigma)-bisbenzimide (5 µl/ml) either with dye alone or in combination with 0.8 µl/ml verapamil. Furthermore, cells were counter stained with 2 µg/ml propidium iodide (PI ;Sigma-Aldrich). The cells were sorted using a flow cytom eter (Attune NxT; Life Technologies, Carlsbad, CA, USA) and the sorted cells were cultured and maintained in DMEM/F-12 supplemented with 10% FBS. The Hoechst 33342 dye was excited at 355 nm and its dual-wavelength fluorescence was analyzed with an optical filter (blue, 450 nm and red, 675 nm; Omega Optical, Brattleboro, VT, USA). For ABCG2 expression, SP and MP cells were incubated with mouse anti-human ABCG2 antibodies (cat. no. ab95692; 1L200; Abcam) at 4˚C overnight. After washing in PBS, cells were combined with horseradish peroxidase-conjugated goat anti-mouse IgG (cat. no. an6789; 1;500; Abcam) and incubated for 30 min at RT. Cells were counterstained with hematoxylin and mounted with glycerol vinyl alcohol aqueous mounting solution (16) . Under an optical microscope (BX51M; Olympus, Tokyo, Japan), the red ABCG2-positive cells were observed.
The immunostaining of tumor spheres generated by SP cells was performed as described previously (17) . Spheres were fixed onto glass slides in ice-cold 4% paraformaldehyde (4˚C, 10 min), and blocked with normal serum for 30 min. The cells were then incubated with mouse monoclonal anti-Oct-4 and -CD44 (1:200; Chemicon, Tokyo, Japan) overnight. After washing the slides with PBS, they were incubated with FITC-conjugated goat anti-mouse IgG overnight in a dark room. Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI) and viewed under a fluorescence microscope (LSM 510; Carl Zeiss GmbH, Jena, Germany). All images were processed with Adobe Photoshop CS5 (Adobe Systems, Inc., CA, USA).
Cell resistance assay. Approximately 1x10
3 cells/plate were cultured in 96-well plates and treated with 10 µg/ml 5-fluorouracil (5-FU; Sigma-Aldrich), 20 µmol/l cisplatin (Sigma-Aldrich), 2 µmol/l paclitaxel (Sigma-Aldrich) and 2 µg/ml docetaxel (Sigma-Aldrich). The mean value of optical density (OD) 450 obtained was presented as a graph. Cell resistance in the two groups was calculated using the following formula: Cell resistance rate (%) = (experimental group OD 450 value/control group OD 450 value) x 100, as described previously (18) .
Reverse transcription (RT)-quantitative polymerase chain reaction (PCR).
Total RNA was extracted and complementary DNA was prepared using a reverse transcriptase kit (Fermentas, Vilnius, Lithuania). First-strand cDNA synthesis and qPCR were performed using the PrimeScript RT-PCR kit (Takara, Otsu, Japan) and the SYBR Premix Ex Taq II kit (Takara, Otsu, Japan), according to the manufacturer's instructions. RT-qPCR analysis was subsequently performed on an iCycler IQ real-time detection system (Bio-Rad, Hercules, CA, USA), using IQ Supermix with SYBR-Green (Bio-Rad). The sequences of human specific primers used were as follows: Forward: CTGGCTTTGGTGAACTGTTG and reverse: AGTTGCTCACAGCCAAGACA for AXIN2; forward: AGCACCTTGGATGGGTATTC and reverse: CACA ATCC TGAG G CACAGTCDK K1 for DK K1; forward: TCAATCAAAGTGCTTCTTTTTTATG and reverse: TTGTGGAAGAATCACGTGGCABCG2 for ABCG2; forward: ATGTCGTGGAGTCTACTGGC and reverse: TGACCTTGCCCACAGCCTTG for GAPDH; and forward: CTCCCAACTGGTTCGACCTT and reverse: CGGTTTCCATATTTCTCAGT for BMI-1. The amplified products were separated by electrophoresis on ethidium bromide-stained 1.2% agarose gels. Band intensity was measured by Image J from two independent experiments.
Biochemistry. For western blot analysis, proteins were extracted from the SP and MP cells, and protein concentration was determined using the Bradford assay (19) . Following 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Bio-Rad, Hercules, CA, USA), proteins were transferred to a nitrocellulose membrane (Bio-Rad), the gels were treated with rabbit anti-human ABCG2, actin and Bcl-2 primary antibodies, goat anti-rabbit IgG with alkaline phosphatase markers secondary antibody and a chemiluminescence reagent. Blots were detected and scanned using a densitometer (Bio-Rad GS-710).
Sphere formation assay. A sphere formation assay was performed exactly as described previously (20) . The sorted SP cells and MP were placed at a density of 1,000 cells/ml, resuspended in tumor sphere medium consisting of serumfree 1:1 mixture of Ham's F-12/DMEM (Sigma-Aldrich), N2 supplement (Sigma-Aldrich), 10 ng/ml human recombinant bFGF and 10 ng/ml EGF (R&D Systems, Inc., Minneapolis, MN, USA), and subsequently cultured in ultra-low attachment plates for ~2 weeks. Sorted SP and MP cells were seeded at a low density of 20 cells/l and the number of generated spheres (>100 cells/ml) was counted after 7 days of culture.
Statistical analysis. One-way analysis of variance and Student's t-test was performed to determine the significant difference between the treatment and control groups. Statistical analysis was performed using SAS statistical software (SAS Institute, Inc., Cary, NC, USA). P<0.01 was considered to indicate a statistically significant difference.
Results
Analysis of ABCG2 expression and stem cell surface proteins in SP cells. NPC samples were analyzed for the presence of cancer stem-like SP cells by a Hoechst 33342 dye exclusion technique. During FACS analysis, the dead cells were excluded by PI staining and therefore, the live cells were carefully selected. After setting the gate for the ability of the cells to expel the Hoechst 33342 dye, ~3.9% of the total cells were identified to be SP cells (Fig. 1A) and the remaining cells were considered to be MP cells. The Hoechst 33342 exclusion (Fig. 1B) . The data confirms that the presence of ABC transporters in SP cells are responsible for chemotherapy resistance.
The SP and MP cells were then analyzed to compare the expression level of ABCB2 genes and other stem cell genes, such as OCT-4 and CD44 by fluorescence microscopy. As shown in Fig. 2 , FACS-sorted SP cells showed increased expression of ABCG2, CD44 and Oct-4 compared with MP cells. The increased expression of CD44 and Oct-4 in SP cells indicated that SP cells have a high capacity for self-renewal. In addition to this data, elevated mRNA expression of ABCG2 in SP cells was also observed (Fig. 3A) . Hence, the data clearly suggest that elevated expression of ABCG2, CD44 and Oct-4 in SP cells may be crucial in drug resistance and tumor relapse of NPC.
Abnormal activation of Wntβ-catenin signaling and multi-drug resistance of SP cells. The Wnt/β-catenin signaling pathway has been found to be associated with the self-renewal property of cancer cells. Using a TOPFLASH luciferase reporter assay, it was previously reported that activity of β-catenin-dependent transcription and elevated expression of DKK1 and AXIN2 was found in HNSCC SP cells compared with non-SP cells (21) . Similar to these findings, RT-qPCR results also showed that the expression levels of two Wnt/β-catenin target genes, DKK1 and AXIN2 are significantly elevated in SP cells compared with MP cells (Fig. 3A and B) .
In order to characterize the SP cells, the self-renewal potential and drug resistance of SP cells was analyzed by sphere formation and drug resistance assays. It was observed that SP cells are highly resistant to multiple drugs, such as docetaxel, 5-FU, cisplatin and paclitaxel. The drug-treated SP cells were more resistant and exhibited significantly increased survival rates when compared with MP cells (Fig. 4A) . Furthermore, RT-qPCR and western blot analysis data revealed that SP cells exhibit elevated mRNA expression of the anti-apoptotic gene Bmi-1 (Fig. 4B ) and increased expression of ABCG2 and Bcl-2 protein (Fig. 4C ). ABCG2 and anti-apoptotic factors are crucial factors involved in drug and apoptotic resistance of SP cells. It was also observed that FACS-purified SP cells can generate tumor spheres rapidly and the total number of spheres generated by NPC SP cells are significantly higher than that by MP cells (Fig. 5A) . Furthermore, the NPC SP cell generated tumor spheres are immunopositive for CD44 (Fig. 5B) . The data clearly demonstrated that NPC SP cells are responsible for chemotherapeutic resistance and may be involved in rapid tumor recurrence and invasion. The presence of CSCs results in the failure of treatment due to the development of MRD. Current conventional treatment strategies efficiently kill the majority of the neoplastic cells and but fail to kill the CSCs. According to the CSC theory, CSCs are the predominant factor in multi-drug resistance. These CSCs are also responsible for tumor growth, metastasis and tumor invasion (22) . It was reported that CSCs can survive conventional anticancer therapies owing to the overexpression of efflux pumps, which ultimately contributed to multi-drug resistance (23) . Therefore, it is essential to eliminate the CSCs in order to completely eradicate the tumor and prevent MRD.
The proposed method to identify the CSCs is the FACS-based Hoechst 33342-dye exclusion technique in which a small population of cancer cells efflux this dye and are termed SP cells (22) . These SP cells exhibit the features of CSCs, such as drug resistance, self-renewal capacity, high differentiation potential, expression of stem cell surface markers and apoptosis resistance. Hence, isolation and further characterization of SP cells aids in the development of novel anticancer drugs, which could efficiently target and kill the CSCs.
In the present study, 3.9% of the total cells were observed to be SP cells in the NPC sample using the Hoechst 33342 dye exclusion method. Upon treatment with verapamil, the prevalence of SP cells was reduced to 0.7%, which confirms the existence of the ABC transporter protein. In addition, gene and protein expression studies as well as immunofluorescence clearly showed that SP cells overexpressed the ABC transporter protein, ABCG2. Hence, these findings suggest that chemotherapy resistance of SP cells from NPC actively involves the overexpression of ABCG2.
The OCT-4 gene was shown to be involved in cell proliferation (24) and the survival of CSCs is partly mediated through the Oct-4/Tcl1/Akt1 pathway (25) . Similarly, the cell surface proteoglycans, such as glycoprotein CD44, are important in tumor invasion and metastasis in several types of tumor (26) . Furthermore, the overexpression of CD44 was shown to be involved in chemo-and radioresistance (27) . Also, CSCs are highly resistant to death-inducing signals due to the enhanced expression level of anti-apoptotic proteins and high levels of drug transporters (7, 18) . It was previously reported that NPC samples showed increased expression of CD44 positive cells, which may be responsible for high levels of tumorigenesis and metastasis (2) . In line with these findings, it was also demonstrated that NPC SP cells have increased expression of CD44, Oct-4, Bcl-2 and Bmi-1 compared with MP cells. Therefore, there may be significant functional interaction between ABCG2, CD44, Oct-4, Bmi-1 and Bcl-2 in the contribution of chemotherapy/apoptosis resistance, tumorigenesis and invasion of NPC cells. In addition, it was also demonstrated that FACs purified SP cells showed high resistance to the chemotherapeutic agents and have increased cell survival rates compared with MP cells. These results clearly confirm that overexpression of efflux pumps (ABCG2) and increased expression of anti-apoptotic factor Bcl-2 are the predominant factors, which confer the properties of multidrug resistance and treatment failure in NPC. Furthermore, the SP cells exhibit self-renewal capacity as they generate more tumor spheres than non-SP cells. Recently, it was shown that secretion of certain interleukins, such as IL-3 and IL-4, promotes enhanced survival rates by altering the rate of apoptosis (28) (29) (30) . Therefore, it was also hypothesized that secretion of interleukins in NPC SP cells may be involved in apoptosis resistance.
Notably, it was found that the Wnt/β-catenin pathway is highly activated in NPC SP cells. Abnormal activation of Wnt/β-catenin in HNSCC was shown to be involved in chemotherapy resistance and invasive growth of cancer cells (31) (32) (33) . Similarly, enhanced Wnt/β-catenin pathway activation is the phenotype of NPC SP cells and may also contribute to multi-drug resistance and tumor invasion (31) . However, the detailed mechanism of altered Wnt/β-catenin pathway signaling requires detailed investigation. In conclusion, the data suggest that isolation and characterization of SP cells may provide valuable information to improve cancer treatment and to design a novel anticancer drug that effectively kills CSCs and prevents MRD in NPC.
